CMS Final Rule requires Medicare Advantage algorithms to account for individual circumstances and be reviewed by humans, but plans lack tools to prove compliance and regulators lack tools to verify it
SaaS platform that audits health plan decision algorithms against CMS rules — checks whether individual patient data is actually incorporated, logs human review steps, generates compliance reports, and manages public disclosure of algorithm evidence
Annual SaaS subscription based on plan size, plus consulting engagements for remediation
CMS Final Rule is law, not guidance. Non-compliance risks CMS audit findings, corrective action plans, civil monetary penalties, and exclusion from MA program — existential threats for plans whose entire business IS Medicare Advantage. Compliance officers are actively looking for solutions and finding nothing purpose-built. Pain is acute but concentrated in ~700 organizations.
TAM is roughly $140M–$700M if all ~700 MA organizations adopt algorithm compliance tooling at $200K–$1M/year. Realistically, the SAM is the top 100 organizations (~80% of enrollment) at $300K–$500K ACV = $30M–$50M. This is a strong niche but not a massive market. Expansion into Medicaid managed care and commercial plans using algorithmic UM could double TAM over time.
Health plan compliance budgets are large and non-discretionary. Plans already spend $1M–$10M annually on compliance tooling (Cotiviti, Inovalon). A $200K–$500K tool that prevents a CMS audit finding is trivially justified — a single corrective action plan costs millions in remediation and reputational damage. The buyer (compliance officer) has budget authority and existential motivation.
This is hard. A solo dev cannot build a credible MVP in 4–8 weeks. The product requires: (1) deep CMS regulatory knowledge encoded as auditable rules, (2) ability to ingest or interface with diverse proprietary algorithm architectures (black-box, rules engines, ML models), (3) clinical knowledge to evaluate whether individual circumstances are meaningfully incorporated, (4) audit trail and reporting infrastructure that holds up under CMS scrutiny. Realistic MVP for a small team is 3–6 months, and requires at least one person with healthcare regulatory domain expertise.
No existing product specifically audits MA plan algorithms for CMS individual-circumstances compliance. This is a verified gap. AI governance platforms lack healthcare domain expertise. Healthcare compliance incumbents audit payments, not algorithm logic. Consulting firms cannot deliver continuous SaaS monitoring. The intersection of 'AI auditing' and 'CMS Medicare regulation' is completely unoccupied.
Compliance is ongoing, not one-time. CMS rules require continuous adherence, algorithms change with each update, and audit readiness must be maintained year-round. Plans need continuous monitoring, quarterly reporting, and annual audit preparation. This is a textbook recurring revenue use case — canceling means losing compliance posture. Multi-year contracts with annual price escalation are standard in this market.
- +Regulatory forcing function with hard deadlines (2025–2027) creating urgent, non-discretionary demand
- +Verified market gap — zero purpose-built competitors in CMS algorithm compliance auditing
- +Buyers (compliance officers) have large budgets, executive authority, and existential motivation to purchase
- +High switching costs and strong recurring revenue dynamics once embedded in compliance workflows
- +First-mover advantage in a niche being created by new regulation — can define the category
- !Technical complexity is high — requires both AI auditing expertise and deep CMS regulatory knowledge, a rare combination
- !Incumbents like Cotiviti or Inovalon could build or acquire into this space once demand is proven
- !Access to proprietary plan algorithms is a go-to-market challenge — plans may resist exposing their logic to a third-party tool
- !CMS enforcement may be slow or inconsistent, reducing urgency for plans to invest in proactive compliance tooling
- !Small founding team without healthcare regulatory credentials may lack credibility with enterprise compliance buyers
Third-party algorithmic auditing consultancy founded by Cathy O'Neil. Performs bespoke fairness and bias audits of algorithms across industries including healthcare.
AI governance platform offering risk management, bias auditing, and compliance tracking across regulatory frameworks
Market-leading payment accuracy, risk adjustment, and compliance analytics platform for health plans. Deep relationships with major MA payers. Processes billions of claims.
Enterprise AI governance platform for policy-based risk management. Maps organizational AI usage to regulatory frameworks
AI-powered prior authorization platform that automates clinical review and aims to improve prior auth speed and accuracy for health plans. Raised $100M+.
Start with a compliance documentation and audit-trail tool — not full algorithmic analysis. MVP generates CMS-ready compliance reports: (1) intake questionnaire mapping plan's algorithm usage to CMS rule requirements, (2) checklist tracking whether human review steps are documented for each algorithm, (3) evidence repository for public disclosure requirements, (4) gap analysis report showing where the plan falls short. This is buildable in 8–12 weeks and gets you in the door. Phase 2 adds actual algorithm testing (black-box input/output analysis to verify individual-circumstances sensitivity).
Phase 1: Compliance assessment consulting ($25K–$75K engagements) to validate the problem and build domain expertise → Phase 2: Launch SaaS compliance documentation platform ($50K–$150K/year) → Phase 3: Add automated algorithm auditing and continuous monitoring ($200K–$500K/year) → Phase 4: Expand to Medicaid managed care and commercial plan algorithmic compliance → Phase 5: Pursue CMS endorsement or become de facto standard tool that auditors expect plans to use
3–4 months to first consulting revenue if founders have healthcare regulatory network. 6–9 months to first SaaS contract. The consulting-first approach validates demand and funds product development. First $1M ARR likely 18–24 months from start.
- “its rule allows use of algorithms without resolving uncertainty about what it means to merely use them”
- “must be reviewed by a physician or other appropriate health care professional”
- “must publicly disclose the evidence supporting the criteria”
- “a choice to use systems that scale denial logic faster than actual patient judgment”